Clinical Trial Update: A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors [NA]

View source ↗

Summary

The document reports an ongoing clinical trial evaluating the Cecebot conversational agent to improve insomnia symptoms in stage I–III breast cancer survivors; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Insomnia

Drugs mentioned

• Cecebot

Snippet

Sponsor: University of Washington | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | NA | Status: ACTIVE_NOT_RECRUITING